Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Intravitreal Bevacizumab & Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration

NCT00640640 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT00640640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00640640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Intravitreal Bevacizumab & Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration
Lead sponsor
Sheba Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2007
Completion date
February 28, 2009
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular age related macular degeneration